Sintx Technologies (SINT) Total Debt (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,814.29% |
| Dec 31, 2025 | -99.20% |
| Sep 30, 2025 | 698.17% |
| Jun 30, 2025 | -9.92% |
| Mar 31, 2025 | -41.83% |
| Dec 31, 2024 | 55.22% |
| Sep 30, 2024 | -44.40% |
| Jun 30, 2024 | 3.43% |
| Mar 31, 2024 | -23.36% |
| Dec 31, 2023 | -55.10% |
| Sep 30, 2023 | -36.37% |
| Jun 30, 2023 | -53.74% |
| Mar 31, 2023 | -58.14% |
| Dec 31, 2022 | 2,062.99% |
| Sep 30, 2022 | 30.26% |
| Jun 30, 2022 | 163.73% |
| Mar 31, 2022 | 11.82% |
| Dec 31, 2021 | -168.17% |
| Sep 30, 2021 | -0.20% |
| Jun 30, 2021 | -0.78% |
| Mar 31, 2021 | -66.30% |
| Dec 31, 2020 | 285.10% |
| Sep 30, 2020 | -5.94% |
| Jun 30, 2020 | -49.64% |
| Mar 31, 2020 | 4,544.44% |
| Dec 31, 2019 | -14.29% |
| Sep 30, 2019 | -95.37% |
| Jun 30, 2019 | -58.27% |
| Mar 31, 2019 | 2.45% |
| Dec 31, 2018 | -32.18% |
| Sep 30, 2018 | -74.16% |
| Jun 30, 2018 | 189.31% |
| Mar 31, 2018 | 246.28% |
| Dec 31, 2017 | -41.32% |
| Mar 31, 2017 | -30.54% |
| Dec 31, 2016 | -46.12% |
| Sep 30, 2016 | -47.78% |
| Dec 31, 2015 | -18.06% |
| Sep 30, 2015 | -11.41% |
| Jun 30, 2015 | 1.25% |
| Mar 31, 2015 | 0.61% |
| Dec 31, 2014 | -2.52% |
| Sep 30, 2014 | 46.31% |
| Jun 30, 2014 | -3.82% |
| Mar 31, 2014 | -10.00% |